logo

For the Inventor, By the Inventor

Winnetka, IL, United States of America

Heidi S Camp

USPTO Granted Patents = 9 

Average Co-Inventor Count = 8.1

ph-index = 5

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal9 out of 822 
 
Abbvie Inc.
 patents

Years Active: 2014-2025

Loading Chart...
9 patents (USPTO):Explore Patents
1. 12365689 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2025-07-22),
2. 11993606 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-05-28),
3. 11993605 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2024-05-28),
4. 11976077 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof (2024-05-07),
5. 11795175 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2023-10-24),
6. 11780848 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof (2023-10-10),
7. 11773106 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2023-10-03),
8. 11767326 - Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof (2023-09-26),
9. 8748627 - Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome (2014-06-10),

Sure, here is the article about inventor Heidi S Camp:

Title: The Innovative Journey of Heidi S Camp: Pioneering Advances in Pharmaceutical Processes

Introduction:

Heidi S Camp is a remarkable inventor based in Winnetka, IL, with a remarkable portfolio of five patents to her name. Her contributions to the field of pharmaceutical processes have been significant, particularly in the treatment of rheumatoid arthritis and various spondyloarthritic conditions.

Latest Patents:

Heidi's latest patents revolve around the processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine carboxamide. These patents include advancements in solid state forms, pharmaceutical compositions, methods of treatment, kits, methods of synthesis, and products-by-process.

Career Highlights:

Currently working at AbbVie Inc., Heidi Camp has established herself as a key figure in the pharmaceutical research and development sector. Her dedication to innovative processes has led to groundbreaking advancements in the treatment of rheumatoid arthritis and axial spondyloarthritis.

Collaborations:

Heidi has had the pleasure of collaborating with esteemed colleagues such as Aileen L Pangan and Mohamed-Eslam F Mohamed. Together, they have synergized their expertise to push the boundaries of pharmaceutical processes and treatment methodologies.

Conclusion:

Heidi S Camp's journey as an inventor exemplifies a commitment to excellence and a drive for innovation in the pharmaceutical industry. Her patents and collaborations stand as a testament to her prowess in advancing medical treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…